GeneDx Holdings Corp vs Wheaton Precious Metals Corp — how do they compare? GeneDx Holdings Corp trades at $86.53 (market cap $2.58B), while Wheaton Precious Metals Corp trades at $156 (market cap $71.45B). The key difference: Wheaton Precious Metals Corp is far larger — about 27.7× GeneDx Holdings Corp's market cap, and Wheaton Precious Metals Corp pays a 0.5% dividend while GeneDx Holdings Corp pays none. Which is the better fit depends on your goals.
| WGS | WPM | |
|---|---|---|
Market Cap | $2.58B | $71.45B |
Sector | Technology | Basic Materials |
52-Week High | $167.51 | $165.72 |
52-Week Low | $34.51 | $94.37 |
Enterprise Value | $2.61B | $73.33B |
Dividend Yield | — | 0.5% |
Signals from Pluang's Aura AI — not financial advice
WGS trades at $85.87, down 0.14% today, with a bullish technical signal from moving averages and support at $84. The company reported Q2 2026 revenue of $114.4M, beating estimates, and returned to adjusted profitability early. However, net income remains negative at -$106M for 2026, with high valuation multiples like EV/EBITDA of 161.17. Recent news highlights partnerships and product launches, such as the NPC GenomeComplete initiative with Beren Therapeutics.
Outlook is mixed: strong analyst buy consensus (90.9%) and institutional interest support upside, but profitability challenges and a class action lawsuit pose risks. Revenue growth and operational improvements are key catalysts, yet high debt-to-asset ratios and negative margins require monitoring for sustained recovery.
Wheaton Precious Metals (WPM) trades at $155.11, up 0.08% with a bullish technical outlook and strong institutional support. The company delivered three consecutive quarterly earnings beats, with Q2 2026 EPS of $1.19 beating expectations of $1.15. Revenue surged to $2.31 billion in 2025 with exceptional 64.66% net margins, while cash flow from operations reached $1.90 billion. Analysts maintain 80% buy ratings with a $161.75 consensus target, representing 4.3% upside potential.
WPM's streaming model provides leveraged exposure to precious metals without mining operational risks, supported by fully-funded growth pipeline targeting 50% production increase by 2030. Key risks include commodity price volatility and execution of the ambitious $5.1 billion 2026 investment plan. The stock offers growth potential but requires monitoring of gold/silver price trends and capital deployment efficiency.
Trailing returns across standard periods
GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →Wheaton Precious Metals Corp is a precious metal streaming company. The company has entered into over 20 long-term purchase agreements with 17 different mining companies, for the purchase of precious metals and cobalt. It has streaming agreements covering approximately 19 operating mines and 9 development stage projects. The company's projects include Vale's Salobo mine and silver streams on Glencore's Antamina mine and Goldcorp's Penasquito mine.
Read more on WPM →